Cargando…

Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel

BACKGROUND: Substance use is a leading cause of preventable morbidity and mortality worldwide. Population-wide screening for problematic substance use in primary health care may mitigate the serious health and socio-economic consequences of such use, but the standard Alcohol, Smoking and Substance I...

Descripción completa

Detalles Bibliográficos
Autores principales: Shmulewitz, Dvora, Eliashar, Roi, Levitin, Maor Daniel, Lev-Ran, Shaul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571312/
https://www.ncbi.nlm.nih.gov/pubmed/37828494
http://dx.doi.org/10.1186/s13011-023-00566-7
_version_ 1785119961791856640
author Shmulewitz, Dvora
Eliashar, Roi
Levitin, Maor Daniel
Lev-Ran, Shaul
author_facet Shmulewitz, Dvora
Eliashar, Roi
Levitin, Maor Daniel
Lev-Ran, Shaul
author_sort Shmulewitz, Dvora
collection PubMed
description BACKGROUND: Substance use is a leading cause of preventable morbidity and mortality worldwide. Population-wide screening for problematic substance use in primary health care may mitigate the serious health and socio-economic consequences of such use, but the standard Alcohol, Smoking and Substance Involvement Screening Test (ASSIST 3.1) may be too long for wide-scale screening. How well validated shorter versions (ASSIST-Lite, ASSIST-FC) perform in identifying those with ASSIST 3.1 problematic use in different settings is unclear. METHODS: General population Jewish adults in Israel (N = 2,474) responded to an online survey that included the ASSIST 3.1 and sociodemographics. Across substances (alcohol, tobacco, cannabis, sedatives, prescription stimulants, prescription painkillers), receiver operator characteristic curve analysis determined that ASSIST-FC scores performed better than ASSIST-Lite at identifying those with problematic use, and evaluated differential ASSIST-FC performance by gender or age. Test characteristics and agreement were evaluated for binary ASSIST-FC versions, with ASSIST 3.1 problematic use as the gold standard. RESULTS: ASSIST-FC scores showed high ability to identify ASSIST 3.1 problematic use, with minimal differences by gender or age. Binary ASSIST-FC (most substances: threshold 3+; alcohol: 5+) showed high specificity and positive predictive value, acceptable sensitivity, and good agreement. CONCLUSIONS: The ASSIST-FC, which assesses frequency of use and other’s concerns about use, appears useful for very brief screening in primary care to identify patients who may benefit from intervention. Early identification of those at-risk may prevent more severe consequences and ultimately decrease the significant costs of problematic substance use on the individual and population level. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-023-00566-7.
format Online
Article
Text
id pubmed-10571312
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105713122023-10-14 Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel Shmulewitz, Dvora Eliashar, Roi Levitin, Maor Daniel Lev-Ran, Shaul Subst Abuse Treat Prev Policy Research BACKGROUND: Substance use is a leading cause of preventable morbidity and mortality worldwide. Population-wide screening for problematic substance use in primary health care may mitigate the serious health and socio-economic consequences of such use, but the standard Alcohol, Smoking and Substance Involvement Screening Test (ASSIST 3.1) may be too long for wide-scale screening. How well validated shorter versions (ASSIST-Lite, ASSIST-FC) perform in identifying those with ASSIST 3.1 problematic use in different settings is unclear. METHODS: General population Jewish adults in Israel (N = 2,474) responded to an online survey that included the ASSIST 3.1 and sociodemographics. Across substances (alcohol, tobacco, cannabis, sedatives, prescription stimulants, prescription painkillers), receiver operator characteristic curve analysis determined that ASSIST-FC scores performed better than ASSIST-Lite at identifying those with problematic use, and evaluated differential ASSIST-FC performance by gender or age. Test characteristics and agreement were evaluated for binary ASSIST-FC versions, with ASSIST 3.1 problematic use as the gold standard. RESULTS: ASSIST-FC scores showed high ability to identify ASSIST 3.1 problematic use, with minimal differences by gender or age. Binary ASSIST-FC (most substances: threshold 3+; alcohol: 5+) showed high specificity and positive predictive value, acceptable sensitivity, and good agreement. CONCLUSIONS: The ASSIST-FC, which assesses frequency of use and other’s concerns about use, appears useful for very brief screening in primary care to identify patients who may benefit from intervention. Early identification of those at-risk may prevent more severe consequences and ultimately decrease the significant costs of problematic substance use on the individual and population level. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13011-023-00566-7. BioMed Central 2023-10-12 /pmc/articles/PMC10571312/ /pubmed/37828494 http://dx.doi.org/10.1186/s13011-023-00566-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shmulewitz, Dvora
Eliashar, Roi
Levitin, Maor Daniel
Lev-Ran, Shaul
Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel
title Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel
title_full Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel
title_fullStr Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel
title_full_unstemmed Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel
title_short Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel
title_sort test characteristics of shorter versions of the alcohol, smoking and substance involvement screening test (assist) for brief screening for problematic substance use in a population sample from israel
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571312/
https://www.ncbi.nlm.nih.gov/pubmed/37828494
http://dx.doi.org/10.1186/s13011-023-00566-7
work_keys_str_mv AT shmulewitzdvora testcharacteristicsofshorterversionsofthealcoholsmokingandsubstanceinvolvementscreeningtestassistforbriefscreeningforproblematicsubstanceuseinapopulationsamplefromisrael
AT eliasharroi testcharacteristicsofshorterversionsofthealcoholsmokingandsubstanceinvolvementscreeningtestassistforbriefscreeningforproblematicsubstanceuseinapopulationsamplefromisrael
AT levitinmaordaniel testcharacteristicsofshorterversionsofthealcoholsmokingandsubstanceinvolvementscreeningtestassistforbriefscreeningforproblematicsubstanceuseinapopulationsamplefromisrael
AT levranshaul testcharacteristicsofshorterversionsofthealcoholsmokingandsubstanceinvolvementscreeningtestassistforbriefscreeningforproblematicsubstanceuseinapopulationsamplefromisrael